APOC3 and metabolic dysfunction-associated steatotic liver disease: In result, APOC3 rs2070667 is indicated to be responsible for the deteriorated pathological characteristics in NAFLD patients by, to a large extent, its inhibitory impact on the serum levels of PUFA-containing TGs.